Literature DB >> 24744193

Clinical characteristics, pathological features and surgical outcomes of focal cortical dysplasia (FCD) type II: correlation with pathological subtypes.

Kun Yao1, Xi Mei, Xingzhou Liu, Zejun Duan, Changqing Liu, Yu Bian, Zhong Ma, Xueling Qi.   

Abstract

Focal cortical dysplasia (FCD) type II is a major cause of drug-resistant epilepsy. In order to gain insight into the possible correlations between FCD II pathological pattern and different clinical characteristics (including clinical information, imaging characteristics and surgical outcomes), different clinicopathological characteristics in two types of FCD II were analyzed (especially in FCD IIb). The mean age of seizure onset and disease duration of 78 patients was 11.0 and 11.2 years, respectively. Patients with FCD type IIb had earlier seizure onset compared with those with FCD type IIa. Pathological subtype IIb was predominantly in frontal lobe and subtype IIa was predominantly seen in temporal. Type IIb demonstrated significantly more signal abnormalities in fluid attenuated inversion recovery (FLAIR) images and T2 images than Type IIa. The rate of satisfactory seizure outcome was 67.64 % in the FCD IIa group, while relative higher, 88.63 %, in the FCD IIb group. All these characteristics may assist in their earlier diagnosis and improve the predictability of surgical management.

Entities:  

Mesh:

Year:  2014        PMID: 24744193     DOI: 10.1007/s10072-014-1782-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  21 in total

1.  Predictors of surgical outcome and pathologic considerations in focal cortical dysplasia.

Authors:  D W Kim; S K Lee; K Chu; K I Park; S Y Lee; C H Lee; C K Chung; G Choe; J Y Kim
Journal:  Neurology       Date:  2008-11-12       Impact factor: 9.910

2.  Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.

Authors:  Zhong Ying; Jorge Gonzalez-Martinez; Cristiane Tilelli; William Bingaman; Imad Najm
Journal:  Epilepsia       Date:  2005-11       Impact factor: 5.864

3.  The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico
Journal:  Epilepsia       Date:  2010-11-10       Impact factor: 5.864

4.  Cortical dysplasia: electroclinical, imaging, and neuropathologic study of 13 patients.

Authors:  L Tassi; B Pasquier; L Minotti; R Garbelli; P Kahane; A L Benabid; G Battaglia; C Munari; R Spreafico
Journal:  Epilepsia       Date:  2001-09       Impact factor: 5.864

5.  Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B).

Authors:  Chris Englund; Rebecca D Folkerth; Donald Born; J Matthew Lacy; Robert F Hevner
Journal:  Acta Neuropathol       Date:  2005-05-05       Impact factor: 17.088

Review 6.  Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience.

Authors:  Jason T Lerner; Noriko Salamon; Jason S Hauptman; Tonicarlo R Velasco; Marta Hemb; Joyce Y Wu; Raman Sankar; W Donald Shields; Jerome Engel; Itzhak Fried; Carlos Cepeda; Veronique M Andre; Michael S Levine; Hajime Miyata; William H Yong; Harry V Vinters; Gary W Mathern
Journal:  Epilepsia       Date:  2009-01-21       Impact factor: 5.864

7.  Electroclinical, MRI and surgical outcomes in 100 epileptic patients with type II FCD.

Authors:  Laura Tassi; Rita Garbelli; Nadia Colombo; Manuela Bramerio; Giorgio Lo Russo; Roberto Mai; Francesco Deleo; Stefano Francione; Lino Nobili; Roberto Spreafico
Journal:  Epileptic Disord       Date:  2012-09       Impact factor: 1.819

8.  Factors influencing surgical outcome in patients with focal cortical dysplasia.

Authors:  S Fauser; T Bast; D-M Altenmüller; J Schulte-Mönting; K Strobl; B J Steinhoff; J Zentner; A Schulze-Bonhage
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-06       Impact factor: 10.154

9.  Subdural electrode analysis in focal cortical dysplasia: predictors of surgical outcome.

Authors:  P Widdess-Walsh; L Jeha; D Nair; P Kotagal; W Bingaman; I Najm
Journal:  Neurology       Date:  2007-08-14       Impact factor: 9.910

Review 10.  Malformations of cortical development: burdens and insights from important causes of human epilepsy.

Authors:  Sanjay M Sisodiya
Journal:  Lancet Neurol       Date:  2004-01       Impact factor: 44.182

View more
  3 in total

Review 1.  Post-processing of structural MRI for individualized diagnostics.

Authors:  Pascal Martin; Benjamin Bender; Niels K Focke
Journal:  Quant Imaging Med Surg       Date:  2015-04

Review 2.  Polymorphous low-grade neuroepithelial tumor of the young: case report and review focus on the radiological features and genetic alterations.

Authors:  Yingqian Chen; Tian Tian; Xinwen Guo; Fenfen Zhang; Miao Fan; Huawei Jin; Dawei Liu
Journal:  BMC Neurol       Date:  2020-04-06       Impact factor: 2.474

3.  Surgical Outcome in Extratemporal Epilepsies Based on Multimodal Pre-Surgical Evaluation and Sequential Intraoperative Electrocorticography.

Authors:  Lilia María Morales Chacón; Judith González González; Martha Ríos Castillo; Sheila Berrillo Batista; Karla Batista García-Ramo; Aisel Santos Santos; Nelson Quintanal Cordero; Marilyn Zaldívar Bermúdez; Randis Garbey Fernández; Bárbara Estupiñan Díaz; Zenaida Hernández Díaz; Juan E Bender Del Busto; Abel Sánchez Coroneux; Margarita M Báez Martin; Lourdes Lorigados Pedre
Journal:  Behav Sci (Basel)       Date:  2021-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.